Greater Houston Psychiatric Associates would like to introduce to our patients Spravato® therapy as a potential treatment option for depression. Spravato® therapy is an FDA-approved nasal spray that contains esketamine, a chemical similar to the anesthetic ketamine. This therapy has been shown to be effective in treating adults with treatment-resistant depression who have not responded well to other forms of antidepressant medication. Spravato® therapy is typically used in combination with an oral antidepressant and is administered under the supervision of a healthcare professional in a clinical setting.
Greater Houston Psychiatric Associates is a certified SPRAVATO® REMS treatment center. Spravato®/ Esketamine Nasal Spray is a treatment that involves the administration of Spravato®/ Esketamine by a nasal spray under the direct supervision of a trained mental health care provied followed by a 2 hour monitoring period in a healthcare setting. This required monitoring is part of the Spravato® REMS program due to the potential serious side effects including sedation, possible dissociation and misuse of abuse.
For more information or to schedule an assessment, call our Spravato® Coordinator, 713-346-1548.